A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...

Researchers highlight GPT1 enzymes role in slowing colon cancer progression Researchers uncover new insights into the ...

Ahmedabad: A group of geneticists from India found the first founder mutation or origin of Lynch Syndrome (LS), the most ...

Touati Benoukraf's lab studies predisposition to colorectal cancer and preventative measures. (Submitted by Touati ...

Researchers hunting for a cure for cancer have made a groundbreaking discovery that could turn some cancer cells into 'normal ...

An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with ...

Larotrectinib sulfate is under clinical development by Bayer and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II drugs for Colorectal Cancer have a 25% phase transition ...

t20 2022 live New drugs emerge in large numbers, and EGFR 20ins mutation is no longer a "problem for all ages" Targeted inhibition of key gene mutations may lead to a complete cure for colon cancer ...

INR:1377. rummy 444 51 Merck's "immune + targeted" combination is approved by the European Union as a first-line treatment for advanced renal cancer Targeted inhibit ...